newsio aggregates and links to original sources. We do not own the original images or content. If you believe content infringes on intellectual property rights, contact us — it will be removed at first notice.

business / news / / Livemint

Delays in capacity utilization and muted order inflows have weighed on earnings visibility.

Epigral's CPVC resin and Epichlorohydrin capacity expansions are on track for commissioning in H1 FY27.

KEY POINTS
COMPANIES
Read the full story on Livemint →
Share X LinkedIn

Summarized by Newsio from Livemint. How we summarize →